New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili

Updated on: April 30,2024

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili

Updated on:April 30,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on: January 23,2024

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on:January 23,2024

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d

Updated on: January 21,2024

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d

Updated on:January 21,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on: April 18,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on:April 18,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on: October 24,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on:October 24,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on: March 20,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on:March 20,2024

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on: December 28,2023

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on:December 28,2023

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on: January 07,2024

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on:January 07,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on: January 21,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on:January 21,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on: June 08,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on:June 08,2024